COV — Toxotis Investments Public Income Statement

0.000.00%

Last trade - 00:00

FinancialsMicro Cap

Annual income statement for Toxotis Investments Public, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	Interim Report	ARS	ARS	ARS
Standards:	IFRS	—	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.204	-0.023	0.071	0.112	0.071
Selling / General / Administrative Expenses
Other Operating Expenses
Total Operating Expenses	0.096	0.3	0.102	0.233	0.69
Operating Profit	0.107	-0.323	-0.032	-0.121	-0.619
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.046	-0.43	-0.151	-0.252	-0.756
Provision for Income Taxes
Net Income After Taxes	0.041	-0.409	-0.151	-0.263	-0.642
Minority Interest
Net Income Before Extraordinary Items
Net Income	0.041	-0.409	-0.151	-0.263	-0.642
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.041	-0.409	-0.151	-0.263	-0.642
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.002	-0.02	-0.007	-0.013	-0.031